Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-216790
Filing Date
2026-05-11
Accepted
2026-05-11 16:13:28
Documents
60
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q catx-20260331.htm   iXBRL 10-Q 1580459
2 EX-31.1 catx-ex31_1.htm EX-31.1 16571
3 EX-31.2 catx-ex31_2.htm EX-31.2 16555
4 EX-32 catx-ex32.htm EX-32 12709
  Complete submission text file 0001193125-26-216790.txt   7301985

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT catx-20260331.xsd EX-101.SCH 1303156
64 EXTRACTED XBRL INSTANCE DOCUMENT catx-20260331_htm.xml XML 1139758
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 206-676-0900
Perspective Therapeutics, Inc. (Filer) CIK: 0000728387 (see all company filings)

EIN.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33407 | Film No.: 26963355
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)